Alpina Biotech distributes ImmunoGuide® ELISA technology to enable precision diagnostics across Europe and beyond. The platform provides highly specific immunoassays for detecting biomarkers, supporting clinical labs in delivering accurate, quantitative test results for disease monitoring and research applications.
Funding
Funding not disclosed
Founders
Product
Problem
Clinical and research laboratories often face challenges obtaining highly specific, validated ELISA reagents and standardized protocols, leading to inconsistent biomarker detection and prolonged assay development times.
Solution
ImmunoGuide offers a portfolio of ELISA technology platforms designed for precision diagnostics. The ImmunoGuide® kits include rigorously validated antibodies and reagents that deliver high specificity for target biomarkers. Each kit is accompanied by detailed, step‑by‑step protocols that align with European regulatory standards, enabling laboratories to implement assays quickly and reproducibly. By centralizing reagent quality and workflow guidance, ImmunoGuide helps labs reduce assay variability, accelerate turnaround, and focus on data interpretation rather than assay optimization.
Target Audience
Primary customers are clinical diagnostic laboratories and academic or industry research labs in Europe that require reliable ELISA assays for biomarker detection.
Features
- Fully validated antibody pairs and reagents optimized for ELISA performance
- Comprehensive, standardized protocols that cover assay setup, incubation, and readout
- Compatibility with common plate readers and automation platforms used in European labs
- High specificity and sensitivity across a broad range of clinical and research biomarkers
- Technical documentation that meets EU diagnostic reagent guidelines